[Skip to Content]
[Skip to Content Landing]
Views 287
Citations 0
Invited Commentary
November 2013

Role of Adjuvant Therapy in Postsurgical Quality-of-Life and Functional Impairment

Author Affiliations
  • 1Department of Otolaryngology–Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri
JAMA Otolaryngol Head Neck Surg. 2013;139(11):1109-1110. doi:10.1001/jamaoto.2013.2777

Dziegielewski and colleagues1 present a cohort follow-up study of patients at their institution with oropharyngeal carcinoma (OPC) treated with transoral robotic surgery for primary tumor resection and neck dissection(s) with or without adjuvant therapy. This report seeks to delineate short- and long-term function, quality of life (QOL), and predictors of their poor outcome (univariable) in a population of patients with OPC and 85% positivity for p16 immunohistochemical staining. In so doing, it addresses important issues.

First Page Preview View Large
First page PDF preview
First page PDF preview